Search

Search Constraints

You searched for: Author/Creator Vos, Stephanie J. B.

Search Results

1. A synergistic association of diabetes and AD biomarkers on cognitive decline in persons without dementia?. (20th December 2022)

2. Alzheimer's disease genetic risk variants show brain cell type‐specific associations with protein levels in cerebrospinal fluid. (1st February 2022)

3. Alzheimer's disease genetic risk variants show brain cell type‐specific associations with protein levels in cerebrospinal fluid. (December 2021)

4. Amyloid‐ß aggregation, APOE‐e genotype, and the trajectory of cognitive decline in persons without dementia. (20th December 2022)

5. Associations of AD risk factors with cerebrospinal fluid ATN biomarker profiles in 10, 662 persons without dementia from the Amyloid Biomarker Study. (20th December 2022)

6. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. (19th May 2018)

7. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology. Issue 3 (14th June 2022)

8. Cerebrospinal fluid proteomic profiling of individuals with prodromal Alzheimer's disease classified using two different neurodegenerative biomarkers (N) in A/T/N classification. (1st February 2022)

9. Cerebrospinal fluid proteomic profiling of individuals with prodromal Alzheimer's disease classified using two different neurodegenerative biomarkers (N) in A/T/N classification. (December 2021)

10. Choroid plexus volume is associated with levels of CSF proteins predominantly expressed by the choroid plexus in non‐demented individuals with AD pathophysiology. (20th December 2022)